AL
CRL icon

Airain Ltd’s Charles River Laboratories CRL Stock Holding History

Airain Ltd’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,731
Closed -$1.15M – 873
2017
Q1 		$1.15M Sell
12,731
-5,987
-32% -$508K 0.06% 323
2016
Q4 		$1.43M Buy
+18,718
New +$1.42M 0.11% 185
2016
Q3 		– Sell
-31,718
Closed -$2.62M – 642
2016
Q2 		$2.62M Buy
31,718
+18,331
+137% +$1.51M 0.15% 187
2016
Q1 		$1.02M Buy
13,387
+2,652
+25% +$196K 0.07% 285
2015
Q4 		$863K Sell
10,735
-13,280
-55% -$958K 0.06% 337
2015
Q3 		$1.52M Buy
24,015
+13,494
+128% +$969K 0.09% 273
2015
Q2 		$740K Buy
+10,521
New +$779K 0.04% 421
2014
Q3 		– Sell
-18,931
Closed -$1.01M – 819
2014
Q2 		$1.01M Buy
+18,931
New +$1.04M 0.08% 262
2013
Q4 		– Sell
-17,820
Closed -$824K – 590
2013
Q3 		$824K Sell
17,820
-5,653
-24% -$259K 0.15% 163
2013
Q2 		$963K Buy
+23,473
New +$1.01M 0.14% 167

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Airain Ltd's CRL Position: Q2 2017 in Review

Airain Ltd sold out of Charles River Laboratories (CRL) in Q2 2017, closing a stake of 12,731 shares — an estimated $1.15M sold.

Airain Ltd first reported a position in CRL in Q2 2013 and held it in 10 quarters. The position peaked at $2.62M in Q2 2016. 302 funds tracked by Wall St. Rank hold CRL as of Q2 2017.

  • Airain Ltd reported no remaining Charles River Laboratories position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 12,731 Charles River Laboratories shares in Q2 2017, an estimated $1.15M.
  • Airain Ltd first reported a position in Charles River Laboratories in Q2 2013 and held it in 10 quarters.
  • Airain Ltd's Charles River Laboratories position peaked at $2.62M in Q2 2016.
  • 302 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.